Search
Scientists Discover a New Hormone that Can Build Strong Bones
A newly discovered hormone that keeps the bones of breastfeeding women strong could also help bone fractures heal and treat osteoporosis in the broader population.Regenerative Medicine Could Soon Transform Treatment of Musculoskeletal Conditions
UCSF’s Brian Feeley, MD, and Xuhui Liu, MD, in collaboration with Kevin Healy, PhD, received a $1.2 million grant for their lab from the California Institute of Regenerative Medicine to continue pursuing their translational research in regenerative medicine.Knee and Hip Replacements: Tips and Tools to Optimize Your Referrals
Noting the prevalence of osteoarthritis and a general lack of consistency in which patients are referred, orthopedic surgeon Claudio Diaz Ledezma, MD, lays out efficient evaluation strategies for primary care providers.There’s a More Humane Way to Monitor Crohn's and Colitis Patients
IBD, which comprises Crohn’s disease and ulcerative colitis, affects 1.3% of the U.S. population and accounts for 3 million new diagnoses every year.The UCSF Hip Preservation Center: Where Hurting Hips Go to Become Happy Hips
See how our specialists work together and use advanced techniques to address all types of hip injuries in all types of patients, including infants and athletes.First “Neuroprosthesis” Restores Words and Mobility to Man with Paralysis
Researchers at UC San Francisco have developed the first “neuroprosthesis” that has enabled a man with severe paralysis to communicate in sentences, translating signals from his brain to the vocal tract directly into words that appear as text on a screen. Aided by this technology, the man is also able to move a robotic arm to manipulate objects.Saras Ramanathan, MD, Appointed Editor-in-Chief of Journal of Academic Ophthalmology
Saras Ramanathan, MD, has been appointed as Editor-in-Chief of the Journal of Academic Ophthalmology (JAO)Hypertrophic Cardiomyopathy: What's All the HYPE?
Theodore Abraham, MD, discusses hypertrophic cardiomyopathy (HCM) a genetic heart disease in which the myocardium becomes abnormally thick.UCSF Internal Medicine Specialist Celebrated for Diabetes Epidemiology Research
Alka M. Kanaya, MD, UC San Francisco primary care physician and researcher, has been honored with the 2023 Kelly West Award for Outstanding Achievement in Epidemiology from the American Diabetes Association (ADA).UCSF Offers Growing Options for Focal Therapy in Prostate Cancer
In its commitment to tailoring prostate cancer treatment to the needs of each patient, UC San Francisco’s Department of Urology uses focal therapy as an important option for men with clinically significant cancers that are located in one region of the prostate.Evaluation & Common Presentation of Fibroids
Dr. Jeannette Lager examines the presentation of fibroids in ultrasound, MRI and CT imaging.Sorting Cancers by “Immune Archetypes” Represents Potential New Approach to Developing Precision Immunotherapies
Using data from over 300 patient tumors, UCSF researchers have described 12 classes of “immune archetypes” to classify cancer tumors. Their findings, published today in CELL, reveal that cancers from different parts of the body are immunologically similar to one another. These classifications provide unique strategies for enhancing each patient’s choice of cancer immunotherapies.Unconscious Bias in Patient Care: Harms and Paths to Healing
While physicians intend to treat all their patients with equal respect and compassion, studies show that favoritism and other implicit attitudes can emerge, especially in times of stress, affecting medical decisions and care quality.Long COVID: A New Way to Look at a Growing Problem
Synthesizing multiple studies, pulmonologist Brian Block, MD, reveals which patients are at risk for lasting symptoms from infection with the coronavirus (it’s not who you might think).UCSF500 Cancer Gene Panel Test
The UCSF500 Cancer Gene Panel leverages world-class expertise for advanced cancer cases. Designed by our leading cancer specialists, the UCSF500 offers unparalleled depth and precision in genetic analysis.Lung Cancer Screening: Who, How and When to Refer
†horacic radiologist Brett M. Elicker, MD, and thoracic surgeon Johannes Kratz, MD, present about current lung cancer screening guidelines: who, how, and when to refer.Placenta Accreta Spectrum Disorder: Proven Strategies from a Multidisciplinary Team
Placenta accreta spectrum disorder is a varied and increasingly common complication of pregnancy, so ob/gyns need a firm grasp of risk factors and ultrasound signs.UCSF Clinic Fills Unmet Need for Managing Oral Side Effects of Cancer Therapies
As advances in cancer treatments have expanded, so has the number of side effects that impact the mouth. Oral medicine specialists at UC San Francisco are working to mitigate these often-debilitating problems, which affect the majority of patients undergoing or recovering from cancer therapy.Genomic Sequencing Is Changing Diagnosis, Treatment for Patients with Brain Cancer
Patients diagnosed with a type of brain tumor survived for longer when they were treated aggressively with surgery, radiation and chemotherapy.Minimally Invasive Skull Base Surgery Center
The role of minimally invasive skull base surgery is expanding in the management and treatment of benign and malignant tumors of the paranasal sinuses, skull base and intracranial compartment.New Laryngopharyngeal Sensitivity Test Could Transform Patient Care
UCSF researchers have developed a first-of-its-kind technique to objectively evaluate laryngopharyngeal sensation.Burnout Interventions to Benefit Individuals and Systems
Sunita Mutha, MD, discusses common symptoms, the many negative consequences for the health care field, and proven interventions.Lung Transplant Outcomes at UCSF Among the Nation’s Best
For nine consecutive years, the UCSan FranciscoLung Transplant Program has achieved significantly higher-than-expected survival rates following transplant surgery. It is the only lung transplant program in the country with this record.Can Lymph Nodes Boost the Success of Cancer Immunotherapy?
New data from a clinical trial show therapies may activate lymph nodes to produce tumor-tackling T cells.